These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9426090)

  • 1. Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer.
    Bury T; Dowlati A; Paulus P; Corhay JL; Hustinx R; Ghaye B; Radermecker M; Rigo P
    Eur Respir J; 1997 Nov; 10(11):2529-34. PubMed ID: 9426090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography.
    Bury T; Dowlati A; Paulus P; Hustinx R; Radermecker M; Rigo P
    Eur J Nucl Med; 1996 Feb; 23(2):204-6. PubMed ID: 8925857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer.
    Bury T; Barreto A; Daenen F; Barthelemy N; Ghaye B; Rigo P
    Eur J Nucl Med; 1998 Sep; 25(9):1244-7. PubMed ID: 9724372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma.
    Poncelet AJ; Lonneux M; Coche E; Weynand B; Noirhomme P;
    Eur J Cardiothorac Surg; 2001 Sep; 20(3):468-74; discussion 474-5. PubMed ID: 11509265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancer.
    Bury T; Paulus P; Dowlati A; Corhay JL; Weber T; Ghaye B; Schoffers J; Limet R; Albert A; Rigo P; Radermecker M
    Eur Respir J; 1996 Dec; 9(12):2560-4. PubMed ID: 8980969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer.
    Saunders CA; Dussek JE; O'Doherty MJ; Maisey MN
    Ann Thorac Surg; 1999 Mar; 67(3):790-7. PubMed ID: 10215230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging.
    Antoch G; Stattaus J; Nemat AT; Marnitz S; Beyer T; Kuehl H; Bockisch A; Debatin JF; Freudenberg LS
    Radiology; 2003 Nov; 229(2):526-33. PubMed ID: 14512512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
    Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
    Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
    Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.
    Steinert HC; Hauser M; Allemann F; Engel H; Berthold T; von Schulthess GK; Weder W
    Radiology; 1997 Feb; 202(2):441-6. PubMed ID: 9015071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.
    Yi CA; Shin KM; Lee KS; Kim BT; Kim H; Kwon OJ; Choi JY; Chung MJ
    Radiology; 2008 Aug; 248(2):632-42. PubMed ID: 18552311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
    Aquino SL; Fischman AJ
    Chest; 2004 Sep; 126(3):755-60. PubMed ID: 15364753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staging and managing lung tumors using F-18 FDG coincidence detection.
    Roman MR; Rossleigh MA; Angelides S; Walker BM; Dixon J
    Clin Nucl Med; 2001 May; 26(5):383-8. PubMed ID: 11317014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of positron emission tomography for lung cancer staging.
    Albes JM; Dohmen BM; Schott U; Schülen E; Wehrmann M; Ziemer G
    Eur J Surg Oncol; 2002 Feb; 28(1):55-62. PubMed ID: 11869015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Positron emission tomography in the evaluation of intrathoracic lymphatic extension of non-small cell bronchial cancer. A preliminary study of 30 patients].
    Bury T; Corhay JL; Paulus P; Weber T; D'Harcour JB; Limet R; Rigo P; Radermecker MF
    Rev Mal Respir; 1996 Jul; 13(3):281-6. PubMed ID: 8765921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study.
    Kim BT; Lee KS; Shim SS; Choi JY; Kwon OJ; Kim H; Shim YM; Kim J; Kim S
    Radiology; 2006 Nov; 241(2):501-9. PubMed ID: 16966480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
    Darling GE; Maziak DE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Gu CS; Kuruvilla MS; Cline KJ; Julian JA; Evans WK; Levine MN
    J Thorac Oncol; 2011 Aug; 6(8):1367-72. PubMed ID: 21587082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer.
    Taus Á; Aguiló R; Curull V; Suárez-Piñera M; Rodríguez-Fuster A; Rodríguez de Dios N; Pijuan L; Zuccarino F; Vollmer I; Sánchez-Font A; Belda-Sanchis J; Arriola E
    Arch Bronconeumol; 2014 Mar; 50(3):99-104. PubMed ID: 24360985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET in lung cancer staging.
    Coleman RE
    Q J Nucl Med; 2001 Sep; 45(3):231-4. PubMed ID: 11788815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.